Medicare Part B (medical insurance) may cover Rituxan (rituximab) infusions. This is because medical professionals typically administer the medication in a medical setting on an outpatient basis.

LONDON (Reuters) - Lymphoma patients who continue regular infusions of Genentech Inc and Biogen Idec's Rituxan after chemotherapy may live longer than patients who stop, Israeli researchers said on ...

The FDA has approved Pfizer’s biosimilar to Rituxan, a treatment for some cancers and autoimmune diseases. The treatment, named Ruxience, is approved to treat Non-Hodgkin lymphoma, chronic lymphocytic ...

The FDA has approved Adcetris plus Revlimid and Rituxan in adults with relapsed or refractory large B-cell lymphoma. The Food and Drug Administration (FDA) has approved Adcetris (brentuximab vedotin) ...

Truxima (rituximab-abbs) is a prescription drug used to treat certain blood cancers, rheumatoid arthritis, and other conditions. Truxima can cause side effects that range from mild to serious.

PRESQUE ISLE, Maine (WAGM) - Rheumatoid arthritis is a chronic autoimmune disease that primarily affects the small joints and ...

Monjuvi, combined with Revlimid and Rituxan, significantly improves progression-free survival in relapsed/refractory follicular lymphoma, as shown in the inMIND trial. The trial reported a median ...

Rituxan (rituximab) is a type of antibody therapy (biologic) medication that may be used with or without chemotherapy. It destroys or helps your body destroy blood cells that contain cancer. It’s used ...